Award
NIH Reporter #11415932
A patient preference trial of sublingual versus extended-release buprenorphine telemedicine and pharmacy linkage for individuals re-entering the community from jail
Recipient
Not Specified
Award Amount
$1,442,966.00
Ceiling
$1,442,966.00
Awarded
June 23, 2026
Identifier
11415932
A clinical trial awarded by the National Institute on Drug Abuse to study telemedicine and pharmacy linkage for buprenorphine treatment in individuals re-entering the community from jail, comparing sublingual and extended-release forms.
Description
This project involves a clinical trial focusing on telemedicine and pharmacy linkage for buprenorphine treatment among individuals re-entering the community from jail. It aims to compare the effectiveness of sublingual versus extended-release buprenorphine, with a focus on implementation strategies and policy considerations across the United States.